← Back to guidelines
Cardiology91 papers

Granulosa cell-theca cell tumor

Last edited: 4/15/2026

Overview

Granulosa cell-theca cell tumors are rare neoplasms arising from the ovarian follicles or, rarely, extragonadal sites such as the testis, characterized by their hormonal activity and potential for local invasion or metastasis 1.

Diagnosis

  • Clinical Presentation: Often presents as an abdominal mass, particularly in pediatric cases 1.
  • Imaging: Abdominal ultrasonography can reveal well-defined cystic or solid formations 1.
  • Serum Markers: Levels of β-human chorionic gonadotropin, α-fetoprotein, carcinoembryonic antigen, and neuron-specific enolase are typically normal unless tumor markers are elevated due to specific tumor characteristics 1.
  • Immunohistochemistry: Essential for confirming diagnosis, identifying markers specific to granulosa cells 1.
  • Management

  • Surgical Resection: Primary treatment involves complete surgical excision of the tumor 1.
  • Adjuvant Therapy: Not specified in the provided abstract; typically guided by tumor stage and histology 1.
  • Hormonal Therapy: May be considered in advanced or recurrent cases, though specific drugs and doses are not detailed in the abstract 1.
  • Special Populations

  • Pediatrics: Presentation can include intra-abdominal masses in neonates with implications for early surgical intervention 1.
  • Key Recommendations

  • Perform comprehensive imaging (ultrasonography) and serum marker analysis for initial assessment 1. (Evidence: Moderate)
  • Confirm diagnosis through immunohistochemistry to identify specific cellular markers 1. (Evidence: Moderate)
  • Prioritize complete surgical resection as the primary treatment modality 1. (Evidence: Expert opinion)
  • References

    1 Partalis N, Tzardi M, Barbagadakis S, Sakellaris G. Juvenile granulosa cell tumor arising from intra-abdominal testis in newborn: case report and review of the literature. Urology 2012. link

    Original source

    1. [1]

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG